{Reference Type}: Journal Article
{Title}: COVID-19 infection and vaccination in 92 pediatric patients with cutaneous mastocytosis: A retrospective, cross-sectional study.
{Author}: López Sanz P;Guerrero Ramírez C;Manso Córdoba S;Alfaro Martínez ME;Bascuñana Mendoza A;Gómez Sánchez ME;Martínez Martínez ML;Azaña Defez JM;
{Journal}: Pediatr Dermatol
{Volume}: 41
{Issue}: 3
{Year}: 2024 May-Jun 2
{Factor}: 1.997
{DOI}: 10.1111/pde.15551
{Abstract}: Mast cells (MCs) can release a variety of biologically active mediators under different circumstances, such as fever or vaccination. Our aim was to evaluate the incidence and severity of MC activation symptoms induced by SARS-CoV-2 virus (COVID-19) infection and vaccination in a cohort of 92 pediatric patients with cutaneous mastocytosis. Our findings support previous evidence on the safety of COVID-19 infection and vaccination in patients with MC disorders.